Mia Thomaïdou, MSc
Mia will be focusing her research on unexplained pain symptoms, in a pharmacological fMRI study that aims to unravel the functional and neurochemical mechanisms underlying nocebo symptom sensitization and de-sensitization. While she will mainly be working with pain and neuropharmacological inductions in healthy participants, other PhD candidates in the same team will be exploring nocebo symptoms in patient groups, as well as unexplained itch and fatigue symptoms. She is delighted to be standing on the shoulders of scientists in our faculty who have been contributing to the knowledge-base of placebo and nocebo research for years. She is equally delighted about designing novel paradigms that will allow for the investigation of the neural correlates of medically unexplained pain, by combining long-established classical conditioning paradigms with cutting-edge brain imaging methods.Back to the people page
News and events
Andrea Evers about healthy lifestyle behaviour at BNR Beter On 8th October Andrea Evers, from the Health, Medical and Neuropsychology unit of Leiden University, appeared as a guest in BNR Beter to talk about a healthy lifestyle behaviour
Scientists present NeuroLabNL research agenda to ministers What effect does bullying have on the brain? This is just one of the key research questions included in the NeuroLabNL science agenda. Scientists presented the agenda to Ministers Van Engelshoven and Dekker on 3 July at Campus The Hague.
First guidelines for applying placebo effect in clinical practice It is becoming increasingly clear that the placebo effect has a great influence on medical treatment. An international, interdisciplinary team of researchers has now written a first set of guidelines on how to apply the placebo effect in clinical practice
Symposium 'Clinical Implications of Placebo Effects' On 21 June, 2018 a symposium about clinical implications of placebo effects will be held in Museum Boerhaave, Leiden.
With Regine Klinger, Luana Colloca, and Andrea Evers as speakers